The total pharmaceutical market in Norway was valued at 55.4 in 2023. Based on forecasted data, the market is expected to grow steadily from 56.6 in 2024 to 61.4 in 2028. This indicates a positive growth trend observed in the pharmaceutical sector.
- Year-on-year growth from 2023 to 2024: 2.17%
- Year-on-year growth from 2024 to 2025: 2.12%
- Year-on-year growth from 2025 to 2026: 2.08%
- Year-on-year growth from 2026 to 2027: 2.03%
- Year-on-year growth from 2027 to 2028: 2.00%
- CAGR from 2023 to 2028: 2.08%
The steady growth forecast for the pharmaceutical market in Norway reflects an expanding demand for generics, consistent advances in healthcare, and an aging population. Future trends to watch include regulatory changes, the impact of technological advancements in medicine, and shifts in healthcare policies that may influence the generics sector. Keeping an eye on these factors could provide insights into market dynamics and potential opportunities for growth and investment.
